The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome

References

• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnosis criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853–61.
   PubMed Web of Science ®Google Scholar
• Murray R. Polycystic ovary syndrome, obesity and insulin resistance: the new female triad. Adv Nurse Pract 2004; 12:22–35.
   PubMedGoogle Scholar
• Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 2006:29;270–80.
   PubMed Web of Science ®Google Scholar
• Staiger H, Haring HU. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes 2005;113:67–79.
   PubMed Web of Science ®Google Scholar
• Yang Q, Graham TE, Mody N, Pritner F, Peroni OD, Zabolotny JM, Kotani K, Quadro I, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356–62.
   PubMed Web of Science ®Google Scholar
• Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989;10:308–16.
   PubMed Web of Science ®Google Scholar
• Newcomer ME, Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta 2000;1482:57–64.
   PubMed Web of Science ®Google Scholar
• Muoio DM, Newgard CB. Metabolism: a is for adipokine. Nature 2005;436:337–8.
   PubMed Web of Science ®Google Scholar
• Graham TE, Yang Q, Bluher M, Hammarsted A, Claraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552–63.
   PubMed Web of Science ®Google Scholar
• Haider DG, Schindler K, Prager G, Bohdjahan A, Luger A, Wolzt M, Ludvik B. Serum retinol binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007; 92:1168–71.
   PubMed Web of Science ®Google Scholar
• Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by life style intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92:1971–4.
   PubMed Web of Science ®Google Scholar
• Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z, Qifu L. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 2006;30:283–7.
   PubMed Web of Science ®Google Scholar
• Lee JW, Im JA, Lee DC, Lee HR, Shim JY. Retinol-binding protein in nonobese women with polycystic ovary syndrome. Clin Endocrinol (OXF) 2008;68:786–90.
   PubMed Web of Science ®Google Scholar
• Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS. Raised serum, adipocyte, and adipose tissue retinol binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 2007;92:2764–72.
   PubMed Web of Science ®Google Scholar
• Chan TF, Tsai YC, Chiu PR, Chen YL, Lee CH, Tsai M. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome. Fertil Steril 2010;93: 869–73.
   PubMed Web of Science ®Google Scholar
• Hutchison SK, Harrison C, Stepto V, Meyer C, Teede HJ. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care 2008;31:1427–32.
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Bozdag G, Otegen U, Harmanci A, Boynukalin K, Vural Z, Kirazli S, Yarali H. Visfatin and retinol-binding protein 4 concentration in lean, glucose-tolerant women with PCOS. Reprod Biomed Online 2010;20:150–5.
   PubMed Web of Science ®Google Scholar
• Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE. Retinol binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol 2007;157:201–7.
   PubMed Web of Science ®Google Scholar
• Aigner E, Bachofner N, Klein K, De Geyter C, Hohla F, Patsch W, Datz C. Retinol-binding protein 4 in polycystic ovary syndrome – association with steroid hormones and response to pioglitazone treatment. J Clin Endocrinol Metab 2009;94:1229–35.
   PubMed Web of Science ®Google Scholar
• Möhlig M, Weickert MO, Ghadamgahi E, Arafat A, Spranger J, Pfeiffer AFH, Schofl C. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur J Endocrinol 2008;158:517–23.
   PubMed Web of Science ®Google Scholar
• Jellife DB. The assessment of the nutritional status of the community. Geneva: WHO, 1966.
   Google Scholar
• Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Popassotiriou I, Margdi A. Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome. J Endocrinol Invest 2008;31: 950–5.
   PubMed Web of Science ®Google Scholar
• Barber TM, Hazell M, Christodoulides C, Golding SJ, Alvey C, Burling K, Vidal-Puig A, Groome NP, Wass JA, Franks S, McCarthy MI. Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J Clin Endocrinol Metab 2008;93:2859–65.
   PubMed Web of Science ®Google Scholar
• Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Faschauer M, Stumvoll M, Bluher M, Kahn BB. Serum retinol-binding protein in more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6:79–87.
   PubMed Web of Science ®Google Scholar
• Palmer MR, Gordon CM, Kartashov AL, Legro RS, Emans SJ, Dunailf A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1017–23.
   PubMed Web of Science ®Google Scholar
• Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001;86: 66–71.
   PubMed Web of Science ®Google Scholar
• Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation and response to pioglitazone. J Clin Endocrinol Metab 2007;92:2590–7.
   PubMed Web of Science ®Google Scholar